Работы, цитирующие эту работу

Работ: 2

Работа: European Association for the Study of the Liver (<scp>EASL</scp>), European Association for the Study of Diabetes (<scp>EASD</scp>) and European Association for the Study of Obesity (<scp>EASO</scp>) clinical practice recommendations for the management of non‐alcoholic fatty liver disease: evaluation of their application in people with Type 2 diabetes

1. Ursodeoxycholic acid as a means of preventing atherosclerosis, steatosis and liver fibrosis in patients with nonalcoholic fatty liver disease

   M. Yu. Nadinskaia, М. V. Maevskaya, В. Т. Ивашкин +9

   СтатьяLiver Disease Diagnosis and TreatmentWorld Journal of Gastroenterology2021Цитирований: 0

   ABIABI:AkademIndex/openalex/2021.article.000032

2. A case-control study of the link between quantity and quality of dietary carbs scores and non-alcoholic fatty liver disease

   Fateme Moradi, Murodjon Yaxshimuratov, Zainab Shateri +5

   СтатьяLiver Disease Diagnosis and TreatmentBMC Nutrition2026Цитирований: 0

   ABIABI:AkademIndex/openalex/2026.article.000534